Anaplastic Thyroid Carcinoma, Version 2.2015.

Details

Serval ID
serval:BIB_A3CD5AB458B5
Type
Article: article from journal or magazin.
Collection
Publications
Title
Anaplastic Thyroid Carcinoma, Version 2.2015.
Journal
Journal of the National Comprehensive Cancer Network
Author(s)
Haddad R.I., Lydiatt W.M., Ball D.W., Busaidy N.L., Byrd D., Callender G., Dickson P., Duh Q.Y., Ehya H., Haymart M., Hoh C., Hunt J.P., Iagaru A., Kandeel F., Kopp P., Lamonica D.M., McCaffrey J.C., Moley J.F., Parks L., Raeburn C.D., Ridge J.A., Ringel M.D., Scheri R.P., Shah J.P., Smallridge R.C., Sturgeon C., Wang T.N., Wirth L.J., Hoffmann K.G., Hughes M.
ISSN
1540-1413 (Electronic)
ISSN-L
1540-1405
Publication state
Published
Issued date
09/2015
Peer-reviewed
Oui
Volume
13
Number
9
Pages
1140-1150
Language
english
Notes
Publication types: Journal Article ; Practice Guideline
Publication Status: ppublish
Abstract
This selection from the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Thyroid Carcinoma focuses on anaplastic carcinoma because substantial changes were made to the systemic therapy recommendations for the 2015 update. Dosages and frequency of administration are now provided, docetaxel/doxorubicin regimens were added, and single-agent cisplatin was deleted because it is not recommended for patients with advanced or metastatic anaplastic thyroid cancer.
Keywords
Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Carboplatin/administration & dosage, Docetaxel, Doxorubicin/administration & dosage, Humans, Paclitaxel/administration & dosage, Radiotherapy, Intensity-Modulated, Taxoids/administration & dosage, Thyroid Carcinoma, Anaplastic/diagnosis, Thyroid Carcinoma, Anaplastic/secondary, Thyroid Carcinoma, Anaplastic/therapy, Thyroid Neoplasms/diagnosis, Thyroid Neoplasms/pathology, Thyroid Neoplasms/therapy, Thyroidectomy
Pubmed
Web of science
Open Access
Yes
Create date
27/12/2020 14:00
Last modification date
28/12/2020 6:26
Usage data